| Literature DB >> 24265698 |
King-Wah Chiu1, Shue-Shian Chiou.
Abstract
Gastroendoscopy (GS) procedures are not only performed by gastroenterologists (GE) but also by hepatologists (HT) in many countries. Endoscopic biopsy (EBx) remains the gold standard for the investigation and documentation of esophago-gastro-duodenal pathology. EBx is subjectively performed by an endoscopist, and the level of skill and experience of the endoscopist may affect the quality of the endoscopic service. Reasons for this discrepancy included lack of experience practitioners to order EBx when required of GS issues between in GE and HT limit access. Ideally, services should be safe and of high quality. This study assessed the EBx/GS ratio as the endoscopic quality assurance as an index of GS services. This was a cohort study of endoscopists at Kaohsiung Chang Gung Memorial Hospital, a teaching hospital in southern Taiwan. There were 34,570 episodes of EBx in 199,877 GS procedures. The 25 endoscopists were divided into GE (n = 13) and HT (n = 12) groups, and correlation coefficients were calculated over a 14.5-year duration of intervention. The Trimmean of EBx/GS was 19.29% in 14.5 years (34570/199877 with Trimmean 0.2 percentile ratio correlations), and the Pearson correlation coefficient was 0.90229. There were significantly more EBx procedures in the GE group than in the HT group at 1 and 5 years (21.5% vs. 15.1% and 20.9% vs. 17.3%, respectively, P<0.00001). Junior GE attempted significantly more EBx than both the senior GE (24.06% vs. 20.41%, P<0.0001), and junior HT (24.06% vs. 13.2%, P<0.0001). In conclusion, quality assurance for gastrointestinal endoscopy involves numerous aspects of unit management and patient safety. Quality measures used with the EBx/GS ratio may be one of the best ways to ensure the quality of endoscopic procedures in a teaching hospital.Entities:
Mesh:
Year: 2013 PMID: 24265698 PMCID: PMC3827051 DOI: 10.1371/journal.pone.0078557
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Indications for upper endoscopies for the gastroenterologists and hepatologists.
| Indications for endoscopy | GE (%) | HT (%) |
| |
| UGI bleeding | 2597 (1.1) | 911 (0.9) | <0.0001 | |
| PU | 149 (0.1) | 142 (0.1) | 0 | |
| Esophagus | GERD | 7716 (3.4) | 5037 (4.9) | <0.0001 |
| Ulcer | 4786 (2.1) | 2348 (2.3) | <0.0001 | |
| Cancer | 2584 (1.1) | 525 (0.5) | <0.0001 | |
| Polyp | 1016 (0.4) | 278 (0.3) | <0.0001 | |
| Submucosa tumor | 1421 (0.6) | 258 (0.3) | <0.0001 | |
| Varices | 10523 (4.6) | 6686 (6.6) | <0.0001 | |
| Mallory Weiss | 188 (0.1) | 12 (0.0) | <0.0001 | |
| Hiatus herniation | 5907 (2.6) | 1488 (1.5) | 0 | |
| Achalasia | 403 (0.2) | 30 (0.0) | <0.0001 | |
| Barrett | 991 (0.4) | 158 (0.2) | <0.0001 | |
| Other | 5933 (2.6) | 488 (0.5) | 0 | |
| Stomach | Gastritis | 57055 (24.9) | 21822 (21.4) | 0 |
| Erosion | 24982 (10.9) | 17613 (17.3) | <0.0001 | |
| Ulcer | 30477 (13.3) | 14571 (14.3) | 0 | |
| Cancer | 1610 (0.7) | 708 (0.7) | <0.0001 | |
| Polyp | 6441 (2.8) | 3041 (3.0) | <0.0001 | |
| Submucosa tumor | 4719 (2.1) | 1021 (1.0) | 0 | |
| Lymphoma | 312 (0.1) | 64 (0.1) | <0.0001 | |
| Chronic Gastritis | 9230 (4.0) | 1316 (1.3) | 0 | |
| Varices | 3354 (1.5) | 2093 (2.1) | <0.0001 | |
| Angiodysplasia | 933 (0.4) | 292 (0.3) | <0.0001 | |
| Xanthoma | 2058 (0.9) | 927 (0.9) | <0.0001 | |
| Marginal ulcer | 836 (0.4) | 420 (0.4) | <0.0001 | |
| Stomal gastritis | 1246 (0.5) | 880 (0.9) | <0.0001 | |
| PHG | 976 (0.4) | 1462 (1.4) | <0.0001 | |
| Endoscopic treatment | 2002 (0.9) | 909 (0.9) | <0.0001 | |
| EVL | 1295 (0.6) | 909 (0.9) | <0.0001 | |
| Other | 5068 (2.2) | 1534 (1.5) | 0 | |
| Duodenum | Ulcer | 19356 (8.5) | 9813 (9.6) | 0 |
| Endoscopic treatment | 287 (0.1) | 80 (0.1) | <0.0001 | |
| Lymphoma | 312 (0.1) | 64 (0.1) | <0.0001 | |
| Endoscopic treatment | 12129 (5.3) | 3911 (3.8) | 0 | |
|
| 228892 (100.0) | 101811 (100.0) | ||
Indications can be more than one selection for each case.
PHG: portal hypertensive gastropathy; PU: peptic ulcer; UGI: upper gastrointestine; EVL: esophageal varices ligation; GE gastroenterologist; GERD; gastroesophageal reflux disease; HT: hepatologist.
Figure 1The ratio of the 34,570 endoscopic biopsies and 199,877 gastroendoscopic services with Trimmean (0.2 percent) correction performed by 27 endoscopists including 15 gastroenterologists and 12 hepatologists over 14.5 years.
The ratio of endoscopic biopsy/gastroendoscopic procedures and Trimmean modified with Trimmean statistical method of Microsoft Office Excel 2007 between the gastroenterologists and hepatologists.
| Category | Gastroenterologist (n = 13) | Hepatologist (n = 12) | ||||||
| EBx | GS | Ratio (%) | Trimmean (%) | EBx | GS | Ratio (%) | Trimmean (%) | |
| 1 year | 2261 | 10503 | 21.5a | 22.23 | 775 | 5149 | 15.1a | 16.50 |
| 5 years | 11185 | 53492 | 20.9%b | 22.36 | 4446 | 25679 | 17.3%b | 16.97 |
| 14.5 years | EBx/GS = 34570/199877, (ratio = 17.29%), (mean = 19.87±8.14%), (Trimmean = 19.29%) | |||||||
Statistic analysis used with Trimmean method of Microsoft Office Excel 2007 with percent = 0.2. A mean trimmed 20% was computed by discarding the lowest and highest 10% of the scores and taking the mean of the remaining scores.
total 27 endoscopists included 15 gastroenterologists and 12 hepatologists; The Pearson correlation coefficient was 0.90229; EBx = endoscopic biopsy; GS = gastroendoscopy;
P<0.0001.
The 5-year endoscopic biopsy/gastroendoscopy ratio of the 25 endoscopists including 13 gastroenterologists and 12 hepatologists and the distribution of senior and junior physicians in our unit.
| Gastroenterologist | Hepatologist | |||||||
| EBx | GS | % | EBx | GS | % | |||
| Senior | 1 | 1077 | 2416 | 44.6 | 1 | 579 | 2060 | 28.1 |
| 2 | 1530 | 5334 | 28.7 | 2 | 401 | 1712 | 23.4 | |
| 3 | 711 | 2848 | 25.0 | 3 | 406 | 1791 | 22.7 | |
| 4 | 965 | 4140 | 23.3 | 4 | 778 | 4043 | 19.2 | |
| 5 | 1170 | 6120 | 19.1 | 5 | 595 | 3304 | 18.0 | |
| 6 | 1318 | 7452 | 17.7 | 6 | 216 | 1344 | 16.1 | |
| 7 | 886 | 5613 | 15.8 | 7 | 212 | 1377 | 15.4 | |
| 8 | 792 | 5415 | 14.6 | 8 | 415 | 2859 | 14.5 | |
| 9 | 973 | 6825 | 14.3 | 9 | 199 | 2303 | 8.6 | |
| Junior | 10 | 199 | 612 | 32.5 | 10 | 253 | 1600 | 15.8 |
| 11 | 717 | 3017 | 23.8 | 11 | 168 | 1234 | 13.6 | |
| 12 | 712 | 3101 | 23.0 | 12 | 224 | 2052 | 10.9 | |
| 13 | 135 | 599 | 22.5 | |||||
| Total | 11185 | 53492 | 20.9a | 4446 | 25679 | 17.3a | ||
| All seniors | 9422 | 46163 | 20.4b, d | 3801 | 20793 | 18.3b, e | ||
| All juniors | 1763 | 7329 | 24.1c, d | 645 | 4886 | 13.2c, e | ||
EBx: endoscopic biopsy; GS: gastroendoscopy;
P<0.0001.
Figure 2The 5-year ratio of endoscopic biopsies and gastroendoscopic services with 95% mean prediction interval to create a standard quality assurance curve with ±5% border distribution.